Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07566390
PHASE1

A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity

Sponsor: Novo Nordisk A/S

View on ClinicalTrials.gov

Summary

The purpose of this clinical study is to find out if NNC0113-5840 is safe for treating people with excess body weight. There are 2 study treatments in this study, participants will get either NNC0113-5840 (the product being tested) or Placebo (treatment that has no active medicine in it), Which treatment participants get is decided by chance.

Official title: A First in Human Dose Study Investigating the Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of NNC0113-5840 in Participants With Overweight or Obesity

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

48

Start Date

2026-05-01

Completion Date

2027-01-31

Last Updated

2026-09-09

Healthy Volunteers

No

Interventions

DRUG

NNC0113-5840

NNC0113-5840 will be administered subcutaneously using needle and syringe in a lifted fold of the abdominal skin.

DRUG

Placebo

Placebo matched to NNC0113-5840 will be administered subcutaneously using needle and syringe in a lifted fold of the abdominal skin.

Locations (2)

PAREXEL Glendale/LA EPCU

Glendale, California, United States

PAREXEL Intl - EPCU-Baltimore

Baltimore, Maryland, United States